New treatment guidelines for chronic lymphocytic leukemia (CLL)
Join Dr. Versha Banerji, a Canadian leader in CLL treatment and research, as she provides the latest information on CLL diagnosis and treatment options.
Dr. Banerji will speak about who the disease affects and how it progresses, how decisions are made about when to treat CLL, the factors that influence the choice of treatment, the new CLL treatments guidelines, and what the future holds.
As co-chair of the CLL Research Program, she manages a multi-disciplinary research team in clinical, fundamental and translational research. Her own laboratory is evaluating novel therapeutics and the impact on mitochondrial function and metabolism.